Study finds 1.5 percent ruxolitinib cream safe, effective for teens with eczema
Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the American Journal of Clinical ...
Jun 1, 2024
0
8